Logo image of ALHEX.PA

HEXAOM (ALHEX.PA) Stock Fundamental Analysis

Europe - EPA:ALHEX - FR0004159473 - Common Stock

29.7 EUR
+2.1 (+7.61%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

4

ALHEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Household Durables industry. ALHEX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALHEX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALHEX had positive earnings in the past year.
ALHEX had a positive operating cash flow in the past year.
Of the past 5 years ALHEX 4 years were profitable.
ALHEX had a positive operating cash flow in each of the past 5 years.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

ALHEX has a Return On Assets (2.48%) which is comparable to the rest of the industry.
The Return On Equity of ALHEX (6.20%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 6.12%, ALHEX is in line with its industry, outperforming 53.13% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALHEX is in line with the industry average of 9.97%.
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROIC 6.12%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 1.94%, ALHEX is in line with its industry, outperforming 53.13% of the companies in the same industry.
ALHEX's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 2.79%, ALHEX is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
ALHEX's Operating Margin has declined in the last couple of years.
ALHEX's Gross Margin of 19.40% is on the low side compared to the rest of the industry. ALHEX is outperformed by 87.50% of its industry peers.
In the last couple of years the Gross Margin of ALHEX has remained more or less at the same level.
Industry RankSector Rank
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALHEX is still creating some value.
Compared to 1 year ago, ALHEX has about the same amount of shares outstanding.
Compared to 1 year ago, ALHEX has an improved debt to assets ratio.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALHEX has an Altman-Z score of 2.48. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.48, ALHEX perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
ALHEX has a debt to FCF ratio of 9.35. This is a negative value and a sign of low solvency as ALHEX would need 9.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.35, ALHEX is in line with its industry, outperforming 59.38% of the companies in the same industry.
ALHEX has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.24, ALHEX is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Altman-Z 2.48
ROIC/WACC0.91
WACC6.75%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

ALHEX has a Current Ratio of 1.30. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
ALHEX has a worse Current ratio (1.30) than 65.63% of its industry peers.
A Quick Ratio of 1.01 indicates that ALHEX should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.01, ALHEX is doing good in the industry, outperforming 65.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.01
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for ALHEX have decreased strongly by -56.88% in the last year.
The earnings per share for ALHEX have been decreasing by -13.22% on average. This is quite bad
The Revenue for ALHEX has decreased by -28.88% in the past year. This is quite bad
ALHEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.93% yearly.
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%

3.2 Future

The Earnings Per Share is expected to grow by 37.93% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALHEX will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y32.2%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.35, the valuation of ALHEX can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of ALHEX indicates a somewhat cheap valuation: ALHEX is cheaper than 62.50% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALHEX to the average of the S&P500 Index (27.38), we can say ALHEX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 10.64, the valuation of ALHEX can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHEX is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, ALHEX is valued rather cheaply.
Industry RankSector Rank
PE 14.35
Fwd PE 10.64
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

96.88% of the companies in the same industry are more expensive than ALHEX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALHEX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 23.68
EV/EBITDA 2.93
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALHEX's earnings are expected to grow with 37.93% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.81%, ALHEX has a reasonable but not impressive dividend return.
ALHEX's Dividend Yield is comparable with the industry average which is at 4.90.
ALHEX's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

HEXAOM

EPA:ALHEX (9/19/2025, 7:00:00 PM)

29.7

+2.1 (+7.61%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-07 2025-05-07
Earnings (Next)09-24 2025-09-24
Inst Owners13.9%
Inst Owner ChangeN/A
Ins Owners2.81%
Ins Owner ChangeN/A
Market Cap206.12M
Analysts86.67
Price Target41.31 (39.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)9.05%
EPS NY rev (3m)9.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.35
Fwd PE 10.64
P/S 0.28
P/FCF 23.68
P/OCF 13.54
P/B 0.9
P/tB 1.52
EV/EBITDA 2.93
EPS(TTM)2.07
EY6.97%
EPS(NY)2.79
Fwd EY9.4%
FCF(TTM)1.25
FCFY4.22%
OCF(TTM)2.19
OCFY7.39%
SpS104.97
BVpS32.84
TBVpS19.59
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROCE 7.89%
ROIC 6.12%
ROICexc 12.79%
ROICexgc 39.35%
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
FCFM 1.2%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexcg growth 3Y-17.24%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Debt/EBITDA 1.55
Cap/Depr 43.08%
Cap/Sales 0.9%
Interest Coverage 250
Cash Conversion 42.9%
Profit Quality 61.63%
Current Ratio 1.3
Quick Ratio 1.01
Altman-Z 2.48
F-Score6
WACC6.75%
ROIC/WACC0.91
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
EPS Next Y32.2%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-41.69%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.7%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-65.3%
OCF growth 3Y-21.91%
OCF growth 5YN/A